Comparison of 6% hydroxyethyl starch(130/0.4) with 5% albumin as intraoperative fluid during major abdominal surgery

Comparison of 6% hydroxyethyl starch(130/0.4) with 5% albumin as intraoperative fluid during major abdominal surgery - Comparison of 6% hydroxyethyl starch(130/0.4) with 5% albumin as intraoperative fluid

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013417

Enrollment

Registered

2014-04-01

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carcinoma of liver, gallbladder, and pancreas

Interventions

6% HES130 administration as intraoperative fluid 5% albumin administration as intraoperative fluid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: adult patients scheduled for major abdominal surgery ASA physical status I, II

Exclusion criteria

Exclusion criteria: preexisting kidney dysfunction, liver dysfunction, coagulopathy, anemia current medication with steroid or diuretics allergy to colloid solution

Design outcomes

Primary

Measure	Time frame
postoperative kidney function and coagulation profile	—

Secondary

Measure	Time frame
biochemical marker of endothelial damage	—

Countries

Japan

Contacts

Public ContactToshinari SUZUKI

Saitama medical center anesthesiology

tsuzuki@saitama-med.ac.jp049-228-3654

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026